Not marked priced sensitive.
Concise ann
fda aligns with
cmc
lot release
dosing and endpoint of trial
Submit by end of year.
For end stage wiith lvad
lets go.
Ann: Mesoblast and FDA Align on Key Items for Revascor BLA, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.49 |
Change
0.000(0.00%) |
Mkt cap ! $3.187B | |||
| Open | High | Low | Value | Volume |
| $2.53 | $2.55 | $2.48 | $9.615M | 3.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $2.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.50 | 4078 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |